Measurement of Homocysteine in Plasma with LCMS-8040

Significance of the Topic

Measurement of homocysteine provides insight into methionine metabolism enzyme activities such as methionine synthase and methylenetetrahydrofolate reductase. Abnormal homocysteine levels are linked to cardiovascular and neurological disorders.

Objectives and Overview of the Study

This application describes a rapid and sensitive method for quantifying total homocysteine in human plasma using the Shimadzu LCMS-8040 triple quadrupole mass spectrometer. It follows the protocol developed by the Mass Spectrometry, Clinical Chemistry and Pharmacology Lab at Meyer Children’s Hospital to assess enzyme activities in research settings.

Methodology and Instrumentation

• Sample Preparation:
  • Plasma (100 µL) mixed with 10 µL d8-homocystine (250 µM) as internal standard and 20 µL DTT (1 mg/mL).
  • Vortex and incubate at room temperature, add 300 µL 0.2 % formic acid–acetonitrile, vortex, then centrifuge at 12 000 rpm for 2 min. Transfer supernatant for analysis.
• Liquid Chromatography:
  • Column: SUPELCO SIL LC-CN (33 mm × 3.0 mm, 3 µm).
  • Mobile phases: A) 0.1 % formic acid in water; B) acetonitrile (70 % B isocratic).
  • Flow: 0.45 mL/min; temperature: 30 °C; injection: 1 µL; total run time: 5 min.
• Mass Spectrometry:
  • Ionization: ESI positive mode (probe +4.5 kV).
  • Gas settings: nebulizer 3.0 L/min; drying 15.0 L/min; DL temperature 200 °C; block heater 350 °C.
  • MRM transitions: homocysteine m/z 135.8 > 90.1; d4-homocysteine m/z 139.8 > 94.1.

Main Results and Discussion

The extracted-ion chromatograms demonstrate:

• No homocysteine peak in enzyme-inactive samples.
• Clear homocysteine signal with internal standard in control samples showing active enzymes.
• Positive control confirms retention time and method specificity.

The method exhibits high selectivity, accuracy, and reproducibility for plasma homocysteine quantification.

Benefits and Practical Applications

• Assessment of methylation cycle enzyme function in research.
• High-throughput capability with a short 5-minute run time.
• Suitable for expanded newborn screening and metabolic disorder studies.

Future Trends and Potential Applications

• Integration with automated sample processing and multi-analyte panels for comprehensive metabolic profiling.
• Clinical validation and compliance for diagnostic use.
• Expansion to high-resolution MS workflows for related thiol metabolites.

Conclusion

The LC-MS/MS protocol on the LCMS-8040 system delivers a streamlined, sensitive, and reliable approach for total homocysteine quantification in plasma. It supports metabolic pathway research and holds promise for broader clinical and screening applications.

References

• la Marca G, et al. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: Update on methods to reduce false positives. JIMD Short Reports #127 (2008).
• Magera JF, et al. Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clinical Chemistry 45(9):1517–1522 (1999).